1351P The impact of BRCA mutation status on NSCLC disease course and response to therapy

Authors :: Alona Zer
S. Laufer-Geva
Elizabeth Dudnik
N. Peled
Yael Goldberg
Ofer Rotem
R. Tschernichovsky
Source :: Annals of Oncology. 31:S866-S867
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Response to therapy
business.industry
Internal medicine
BRCA mutation
medicine
Hematology
business
Disease course

Tools